Navigation Links
Copan Announces Multimillion Expansion for US Pipet Manufacturing Operations
Date:8/27/2009

MURRIETA, Calif., Aug. 27 /PRNewswire/ -- Despite tough economic times, Copan is proud to announce the expansion of its US operations. Copan Diagnostics, Inc. is undertaking a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing operations to its facility in Murrieta, California. The expansion plan includes the addition of blow molding machinery and filling and packing equipment to expand Copan's current capabilities.

To support the expansion, Copan purchased a 13,000 sq ft building adjacent to its current facility to house new plastic blow molding equipment used to manufacture transfer pipets. The new building allows the transfer of some activities from its current location freeing up space to expand medical device manufacturing operations for the company's microbiology specimen collection and transport line. The project is an integral part of Copan's corporate wide plan to support future demand. Norman Sharples, Executive VP, says that "in today's market, companies must examine opportunities to bring further efficiencies to their operations to remain competitive, which is what we are doing with this endeavor."

Plastic transfer pipets are an essential product widely used by hospital, research and industrial laboratories for transferring liquids and clinical samples during diagnostics testing or analytical research. In fact, as many as 500 million pipets are used in the USA annually. Copan has manufactured pipets at its Italian headquarters for over 25 years, and it has developed a customized blow molding equipment that maximizes productivity through a fully automated system for separating molded product from waste material, which is then 100% recycled.

The efficient technology developed and tuned at Copan Italia is now transferred to California. "The decision to bring manufacturing of this product line locally is to be able to bring the product closer to our customers to respond rapidly to their needs," Sharples adds. The initial phase of manufacture will focus on the three most popular pipets: 1ml, 3ml and Blood Banking pipets. During this phase, Copan will produce 300,000 pipets daily with plans to increase production in 2010.

"Copan is excited about this new venture as it greatly expands the capabilities of our US operation and allows Copan to enhance service to our customers. This expansion also marks the 15th anniversary of Copan's operations in the US," Sharples concludes.

About Copan Diagnostics, Inc.

With a reputation for innovation in preanalytics, Copan Diagnostics is the leading manufacturer of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and for molecular diagnostic assays, as well as producing innovations, like the patented Flocked Swabs, Universal Transport Medium and ESwab. The company manufactures a comprehensive line of laboratory consumables comprising of inoculation loops, needles, spreaders and transfer pipets. Copan also produces WASP: Walk-Away Specimen Processor, a revolutionary system for automatic planting and streaking of microbiology samples. For more information about Copan, visit www.copanusa.com


'/>"/>
SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim
2. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... upscale Capitol Hill neighborhood, with its swanky shops, parks and cafés, ... treatment salon to set up shop. But there,s Hair ... bistro on E Madison Ave, and CEO Maria Botham ... clinic, we pride ourselves on being a destination for parents ... stigma associated with lice. Everyone can get lice – it ...
(Date:2/23/2017)... (PRWEB) , ... February 23, ... ... Inc., announced today that in a published evaluation of multiple immunoassay-based threat ... U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was ...
(Date:2/23/2017)... ... , ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC ... GGI's mission is to advance global health and highlight the greater good of clinical ... each clinical trial volunteer. The vision of GGI is to serve as a philanthropic ...
Breaking Biology Technology:
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
Breaking Biology News(10 mins):